JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES

Article

Journal of Clinical and Biomedical Sciences

Year: 2023, Volume: 13, Issue: 4, Pages: 108-114

Original Article

Blinding Induced Risk of Bias in Randomized Controlled Trials of Physiotherapy Interventions — A Retrospective Study

Received Date:29 January 2023, Accepted Date:05 April 2023, Published Date:21 May 2023

Abstract

Introduction: In randomized clinical trials, the methodological idea of preventing bias by withholding knowledge of the allocation status is known as blinding. Blinding refers back to the concealment of group allocation from one or extra individuals concerned in scientific studies, most commonly a randomized controlled trial (RCT). Even though randomization minimizes variations among treatment groups on the outset of the trial, it does nothing to prevent differential treatment of the groups later within the trial or the differential assessment of outcomes, either of which may also bring about biased estimates of treatment outcomes. The most beneficial strategy to limit the chance of differential remedy or assessments of results is to blind as many individuals as viable in a trial. Objective: To study the extent of blinding induced bias in RCT of physiotherapy interventions and to evaluate the extent of interpretative consideration it the trials are not blinded in the sample of RCT included. Methodology : We conducted a retrospective analysis to estimate the blinding bias in the randomized controlled trials published in physiotherapy interventions from 2016 to 2022. Results & Conclusion : We included 50 RCTs for blinding assessment. About 88% of included articles were not having participants blinding 90% has not done therapist blinding and nearly 50% of studies were conducted without assessors blinding. Based on the results of this study blinding of important participants were infrequently reported in the included studies.

Keywords: Blinding, Risk of bias, Physiotherapy, Randomized controlled trials

References

  1. Hróbjartsson A, Boutron I. Blinding in Randomized Clinical Trials: Imposed Impartiality. Clinical Pharmacology & Therapeutics. 2011;90(5):732–736. Available from: https://doi.org/10.1038/clpt.2011.207
  2. Sil A, Kumar P, Kumar R, Das NK. Selection of Control, Randomization, Blinding, and Allocation Concealment. Indian Dermatology Online Journal. 2019;10(5):601–605. Available from: https://doi.org/10.4103/idoj.IDOJ_149_19
  3. Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what. Lancet. 2002;359(9307):696–700. Available from: https://doi.org/10.1016/S0140-6736(02)07816-9
  4. Boutron I, Guittet L, Estellat C, Moher D, Hróbjartsson A, Ravaud P. Reporting Methods of Blinding in Randomized Trials Assessing Nonpharmacological Treatments. PLoS Medicine. 2007;4(2):370–380. Available from: https://doi.org/10.1371/journal.pmed.0040061
  5. Karanicolas PJ, Farrokhyar F, Bhandari M. Blinding: Who, what, when, why, how? Canadian Journal of Surgery. 2010;53(5):345–348. Available from: https://www.canjsurg.ca/content/cjs/53/5/345.full.pdf
  6. Monaghan TF, Agudelo CW, Rahman SN, Wein AJ, Lazar JM, Everaert K, et al. Blinding in Clinical Trials: Seeing the Big Picture. Medicina. 2021;57(7):1–13. Available from: https://doi.org/10.3390/medicina57070647
  7. Iflaifel M, Partlett C, Bell J, Cook A, Gamble C, Julious S, et al. Blinding of study statisticians in clinical trials: a qualitative study in UK clinical trials units. Trials. 2022;23(535):1–11. Available from: https://doi.org/10.1186/s13063-022-06481-9
  8. Saltaji H, Armijo-Olivo S, Cummings GG, Amin M, Costa BRD, Flores-Mir C. Influence of blinding on treatment effect size estimate in randomized controlled trials of oral health interventions. BMC Medical Research Methodology. 2018;18(42):1–18. Available from: https://doi.org/10.1186/s12874-018-0491-0
  9. Freed B, Assall OP, Panagiotakis G, Bang H, Park JJ, Moroz A, et al. Assessing blinding in trials of psychiatric disorders: A meta-analysis based on blinding index. Psychiatry Research. 2014;219(2):241–247. Available from: https://doi.org/10.1016/j.psychres.2014.05.023
  10. Hróbjartsson A, Emanuelsson F, Thomsen ASS, Hilden JS, Brorson S. Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies. International Journal of Epidemiology. 2014;43(4):1272–1283. Available from: https://doi.org/10.1093/ije/dyu115
  11. Renjith V. Blinding in Randomized Controlled Trials: What researchers need to know? Manipal Journal of Nursing and Health Sciences. 2017;3(1):1–7. Available from: https://impressions.manipal.edu/mjnhs/vol3/iss1/14
  12. Probst P, Grummich K, Heger P, Zaschke S, Knebel P, Ulrich A, et al. Blinding in randomized controlled trials in general and abdominal surgery: protocol for a systematic review and empirical study. Systematic Reviews. 2016;5(48):1–6. Available from: https://doi.org/10.1186/s13643-016-0226-4
  13. Armijo-Olivo S, Fuentes J, Costa BRD, Saltaji H, Ha C, Cummings GG. Blinding in Physical Therapy Trials and Its Association with Treatment Effects. A Meta-epidemiological Study. American Journal of Physical Medicine & Rehabilitation. 2017;96(1):34–44. Available from: https://doi.org/10.1097/PHM.0000000000000521
  14. Juul S, Gluud C, Simonsen S, Frandsen FW, Kirsch I, Jakobsen JC. Blinding in randomised clinical trials of psychological interventions: a retrospective study of published trial reports. BMJ Evidence-Based Medicine. 2021;26(3):109. Available from: http://dx.doi.org/10.1136/bmjebm-2020-111407
  15. Bespalov A, Wicke K, Castagné V. Blinding and Randomization. In: BA, MMC, ST., eds. Good Research Practice in Non-Clinical Pharmacology and Biomedicine. (Vol. 257, pp. 81-100) Springer International Publishing. 2019.
  16. Speich B. Blinding in Surgical Randomized Clinical Trials in 2015. Annals of Surgery. 2017;266(1):21–22. Available from: https://doi.org/10.1097/SLA.0000000000002242
  17. Rushton A, Calvert M, Wright C, Freemantle N. Physiotherapy trials for the 21st century – time to raise the bar? Journal of the Royal Society of Medicine. 2011;104(11):437–441. Available from: https://doi.org/10.1258/jrsm.2011.110109
  18. Fregni F, Imamura M, Chien HF, Lew HL, Boggio P, Kaptchuk TJ, et al. Challenges and Recommendations for Placebo Controls in Randomized Trials in Physical and Rehabilitation Medicine. American Journal of Physical Medicine & Rehabilitation. 2010;89(2):160–172. Available from: https://doi.org/10.1097/PHM.0b013e3181bc0bbd
  19. Patterson KK. Rehabilitation Research: Who Is Participating? Physiotherapy Canada. 2013;65(3):201–202. Available from: https://doi.org/10.3138/ptc.65.3.GEE
  20. Page SJ, Persch AC. Recruitment, Retention, and Blinding in Clinical Trials. The American Journal of Occupational Therapy. 2013;67(2):154–161. Available from: https://doi.org/10.5014/ajot.2013.006197
  21. Hoover JC, Alenazi AM, Alothman S, Alshehri MM, Rucker J, Kluding P. Recruitment for exercise or physical activity interventions: a protocol for systematic review. BMJ Open. 2018;8(3):1–6. Available from: http://dx.doi.org/10.1136/bmjopen-2017-019546

Copyright

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Published By Sri Devaraj Urs Academy of Higher Education, Kolar, Karnataka

DON'T MISS OUT!

Subscribe now for latest articles and news.